Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)

Germany flag Germany · Delayed Price · Currency is EUR
0.955
-0.030 (-3.05%)
At close: Dec 4, 2025
-8.17%
Market Cap 630.87M
Revenue (ttm) 89.95M
Net Income (ttm) 3.81M
Shares Out n/a
EPS (ttm) 0.01
PE Ratio 165.70
Forward PE 37.31
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.955
Previous Close 0.985
Day's Range 0.955 - 0.955
52-Week Range 0.870 - 2.120
Beta n/a
RSI 27.82
Earnings Date Nov 27, 2025

About FRA:UJ9

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Employees 760
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol UJ9
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.